+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Moist Wound Dressings Market Size, Share & Industry Trends Analysis Report By Application, By End-use, By Product, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 183 Pages
  • September 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5903553
The Europe Moist Wound Dressings Market would witness market growth of 5.0% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 243.5 million Units, showcasing a growth of 4.9% (2019-2022).

The moist wound dressing stimulates collagen synthesis, alleviates discomfort, and encourages keratinocyte migration. Moist wound dressings promote three to five times more rapid healing than dry ones. Keratinocyte cells function more efficiently in a moist environment because they can reach the wound surface quickly. The moist climate generates a hypoxic wound bed, lowers the pH, promotes angiogenesis, and renders the wound bed inhospitable to bacteria. The presence of moisture facilitates topical treatment for tissue and cell transplants. As moist wound dressings play a crucial role in the treatment of both chronic and acute lesions, these factors are expected to drive market growth.

The market is anticipated to expand swiftly as optimally moist environments promote faster wound healing. According to estimates, moist wounds recover three to five times faster than dry wounds. Burns, traumatic injuries, pressure ulcers, venous leg ulcers, and ulcers from diabetes are some of the wound types treated with moist wound dressings. In addition, moist wound dressing accelerates keratinocyte activity, essential for wound healing. Moist healing of wounds stimulates the synthesis of collagen as moisture promotes the production of collagen by fibroblasts. Increased collagen production enables the body to lay down a matrix for new tissue more rapidly, resulting in accelerated healing. These factors will increase the market opportunity for moist wound dressings in the coming years.

Europe boasts well-established and advanced healthcare infrastructure, making it easier for healthcare facilities to adopt and implement innovative wound care solutions, including moist dressings. European regulatory agencies, like the European Medicines Agency (EMA) and national authorities, have stringent medical devices and wound care products standards. Europe attracts patients for medical treatment, including wound care. The availability of advanced wound care products, including moist dressings, can make Europe an attractive destination for patients seeking specialized care. Thus, all these elements will work in synergy to drive the growth of the regional market.

The Germany market dominated the Europe Moist Wound Dressings Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $404.8 million by 2030. The UK market is estimated to grow at a CAGR of 4.1% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 5.8% during (2023 - 2030).

Based on Application, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Surgical & Traumatic Wounds, and Burns). Based on End-use, the market is segmented into Hospitals, Specialty Clinics, Home Healthcare, and Others. Based on Product, the market is segmented into Foam Dressings, Film Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings, Collagen Dressings, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Convatec, Inc., Essity AB, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., Molnlycke Health Care AB, 3M Company, B. Braun Melsungen AG

Scope of the Study

Market Segments Covered in the Report:

By Application (Volume, Million Units, USD Million, 2019-2030)
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others
  • Acute Wounds
  • Surgical & Traumatic Wounds
  • Burns
By End-use (Volume, Million Units, USD Million, 2019-2030)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others
By Product (Volume, Million Units, USD Million, 2019-2030)
  • Foam Dressings
  • Film Dressings
  • Hydrogel Dressings
  • Alginate Dressings
  • Hydrocolloid Dressings
  • Collagen Dressings
  • Others
By Country (Volume, Million Units, USD Million, 2019-2030)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Coloplast Group
  • Medline Industries, Inc.
  • Smith & Nephew PLC
  • Convatec, Inc.
  • Essity AB
  • Integra LifeSciences Holdings Corporation
  • Cardinal Health, Inc.
  • Molnlycke Health Care AB
  • 3M Company
  • B.Braun Melsungen AG

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Moist Wound Dressings Market, by Application
1.4.2 Europe Moist Wound Dressings Market, by End-use
1.4.3 Europe Moist Wound Dressings Market, by Product
1.4.4 Europe Moist Wound Dressings Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scnerio
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Moist Wound Dressings Market by Application
4.1 Europe Chronic Wounds Market by Country
4.2 Europe Moist Wound Dressings Market by Chronic Wounds Application
4.2.1 Europe Diabetic Foot Ulcers Market by Country
4.2.2 Europe Pressure Ulcers Market by Country
4.2.3 Europe Venous Leg Ulcers Market by Country
4.2.4 Europe Others Market by Country
4.3 Europe Acute Wounds Market by Country
4.4 Europe Moist Wound Dressings Market by Acute Wounds Application
4.4.1 Europe Surgical & Traumatic Wounds Market by Country
4.4.2 Europe Burns Market by Country
Chapter 5. Europe Moist Wound Dressings Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Specialty Clinics Market by Country
5.3 Europe Home Healthcare Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Moist Wound Dressings Market by Product
6.1 Europe Foam Dressings Market by Country
6.2 Europe Film Dressings Market by Country
6.3 Europe Hydrogel Dressings Market by Country
6.4 Europe Alginate Dressings Market by Country
6.5 Europe Hydrocolloid Dressings Market by Country
6.6 Europe Collagen Dressings Market by Country
6.7 Europe Others Market by Country
Chapter 7. Europe Moist Wound Dressings Market by Country
7.1 Germany Moist Wound Dressings Market
7.1.1 Germany Moist Wound Dressings Market by Application
7.1.1.1 Germany Moist Wound Dressings Market by Chronic Wounds Application
7.1.1.2 Germany Moist Wound Dressings Market by Acute Wounds Application
7.1.2 Germany Moist Wound Dressings Market by End-use
7.1.3 Germany Moist Wound Dressings Market by Product
7.2 UK Moist Wound Dressings Market
7.2.1 UK Moist Wound Dressings Market by Application
7.2.1.1 UK Moist Wound Dressings Market by Chronic Wounds Application
7.2.1.2 UK Moist Wound Dressings Market by Acute Wounds Application
7.2.2 UK Moist Wound Dressings Market by End-use
7.2.3 UK Moist Wound Dressings Market by Product
7.3 France Moist Wound Dressings Market
7.3.1 France Moist Wound Dressings Market by Application
7.3.1.1 France Moist Wound Dressings Market by Chronic Wounds Application
7.3.1.2 France Moist Wound Dressings Market by Acute Wounds Application
7.3.2 France Moist Wound Dressings Market by End-use
7.3.3 France Moist Wound Dressings Market by Product
7.4 Russia Moist Wound Dressings Market
7.4.1 Russia Moist Wound Dressings Market by Application
7.4.1.1 Russia Moist Wound Dressings Market by Chronic Wounds Application
7.4.1.2 Russia Moist Wound Dressings Market by Acute Wounds Application
7.4.2 Russia Moist Wound Dressings Market by End-use
7.4.3 Russia Moist Wound Dressings Market by Product
7.5 Spain Moist Wound Dressings Market
7.5.1 Spain Moist Wound Dressings Market by Application
7.5.1.1 Spain Moist Wound Dressings Market by Chronic Wounds Application
7.5.1.2 Spain Moist Wound Dressings Market by Acute Wounds Application
7.5.2 Spain Moist Wound Dressings Market by End-use
7.5.3 Spain Moist Wound Dressings Market by Product
7.6 Italy Moist Wound Dressings Market
7.6.1 Italy Moist Wound Dressings Market by Application
7.6.1.1 Italy Moist Wound Dressings Market by Chronic Wounds Application
7.6.1.2 Italy Moist Wound Dressings Market by Acute Wounds Application
7.6.2 Italy Moist Wound Dressings Market by End-use
7.6.3 Italy Moist Wound Dressings Market by Product
7.7 Rest of Europe Moist Wound Dressings Market
7.7.1 Rest of Europe Moist Wound Dressings Market by Application
7.7.1.1 Rest of Europe Moist Wound Dressings Market by Chronic Wounds Application
7.7.1.2 Rest of Europe Moist Wound Dressings Market by Acute Wounds Application
7.7.2 Rest of Europe Moist Wound Dressings Market by End-use
7.7.3 Rest of Europe Moist Wound Dressings Market by Product
Chapter 8. Company Profiles
8.1 Coloplast Group
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Smith & Nephew PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional and Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 3M Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Molnlycke Health Care AB
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Medline Industries, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 ConvaTec Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.10. Essity AB
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Companies Mentioned

  • Coloplast Group
  • Medline Industries, Inc.
  • Smith & Nephew PLC
  • Convatec, Inc.
  • Essity AB
  • Integra LifeSciences Holdings Corporation
  • Cardinal Health, Inc.
  • Molnlycke Health Care AB
  • 3M Company
  • B. Braun Melsungen AG

Methodology

Loading
LOADING...